Javelin Pharmaceuticals to Present at the 2008 UBS Warburg Global Life Sciences Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (AMEX: JAV) announced today that Martin J. Driscoll, the Company’s Chief Executive Officer, will provide a corporate overview at the 2008 UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York City, Monday, September 22, 2008 at 12 Noon EDT.

MORE ON THIS TOPIC